Probiotics China News Bites – March 2022

  • Novozymes conducted a comprehensive consumer survey in March, pointed out that in the post-epidemic era, consumers are more concerned about their physical and mental health, and are more inclined to choose natural and clean products. From the perspective of the consumer market, the categories between products have become blurred, and there are often “cross-border” products found in the market; more and more consumers are beginning to accept e-commerce and start shopping online; more diverse and personalized services appear in the market. For young consumers, affected by the epidemic, they are more concerned about their mental health, and they are more inclined to consume products for mental problems.
  • Novozymes announced the official appointment of Mr. Cheng Xian as the general manager of Novozymes OneHealth (Shanghai) Co., Ltd. in China, responsible for Novozymes OneHealth Greater China business.
  • Novozymes and Jean-Marc Sabaté/Franck Iglicki of Avicenna Hospital in France published a paper, finding that Bifidobacterium longum 35624 can significantly relieve irritable bowel syndrome and improve the life quality of patients.
  • AB-Biotics released the latest clinical study revealing the potential effect of its probiotic formula AB-Kolicare on infant gastrointestinal diseases.
  • The 427-million-yuan worthy new plant in Nanke city of SynBio Group started construction. It is expected to be officially opened in the second half of 2024. After that, the production capacity will be expanded to five times as the current capacity.
  • Chr. Hansen published the results of a survey of 16,000 consumers in 16 countries. Most consumers are eager to learn more about probiotics, and 50% of consumers are familiar or very familiar with the “gut microbiome”. 48% of respondents take probiotics almost daily through supplements or other foods.
  • According to the “Administrative Measures for Group Standards of China Nutrition and Health Food Association”, By-Health Co., Ltd. and other companies jointly drafted the group standard of “Standards for the Classification of Viable Bacteria in Probiotic Foods”.
  • Pan Lelai launched mood probiotics to relieve anxiety and depression in young people.
  • The Bright Food Group launched Helical probiotics, adding European star patent strain Lactobacillus reuteri Pylopass*, Bright patent strain Lactobacillus plantarum ST-III and -Bifidobacterium lactis V9 isolated from the intestines of healthy children, and some other strains etc.
  • Probi launches S. salivarius BLIS K12 strain which can be used to support natural immune defenses and prevent mouth and throat infections and help form healthy teeth and gums.
  • Tate & Lyle will acquire Quantum Hi-Tech, a prebiotic manufacturer, for US$237 million.
  • The “Southern Milk Source Probiotic Bacteria Screening and Resource Bank Construction” project jointly completed by Ausnutria and Hunan Agricultural University successfully passed the evaluation of Scientific and Technological Achievements
  • Hei Zero, a future food brand of Bloomage Bio, announced the launch of a new probiotic product that contains 50 billion live probiotics, including 9 strains of gastrointestinal bacteria and 1 strain of oral bacteria.
  • NutritionCare launched a functional probiotic product, NC Soufflé Probiotics, for people with sleep disorders.
  • High Change launched new U-crown probiotics lyophilized powder with vacuum freeze-drying at minus 40℃ and vacuum embedding technologies.
  • Infinitus launched a new brand, “Lezi Leyan”, which includes three new products, X-Mei High Protein Cereal Bar, X-Mei Probiotic Solid Drink and Fiber Powder Solid Drink.
  • WonderLab launched two new products: children’s probiotics ready-to-eat powder and children’s probiotics chewable tablets.
  • Fonterra NZMP and Maypro enter into a retail agreement to supply HN001 and HN019 probiotics to North America.
  • Nanyang Technological University uses alginate to protect probiotics from stomach acid damage.

(Source: HPA-China)